Home / Stocks / Manali Petrochemicals Lt
MANALIPETC

Manali Petrochemicals Lt Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹77.57

Change

-0.96 (-1.22%)

Open

₹78.5

Prev. Close

₹78.53

Day High

₹78.68

Day Low

₹76.52

Volume Analysis

Traded

320,675

Delivered

116,796

Delivery %

36.42%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Low return on equity (4.38%)

Opportunities (1)

  • •Strong 3-year EPS growth (36.9%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹80.82 ₹79.75 ₹78.66 ₹77.59 ₹76.5 ₹75.43 ₹74.34
Fibonacci ₹79.75 ₹78.92 ₹78.42 ₹77.59 ₹76.76 ₹76.26 ₹75.43
Camarilla ₹78.16 ₹77.97 ₹77.77 ₹77.59 ₹77.37 ₹77.17 ₹76.98

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+23.4%

1 Week

-3.59%

1 Month

-0.19%

3 Months

+4.8%

6 Months

+23.24%

1 Year

+16.66%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹68.73

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

55.91%

Net margin 18.6% × asset turnover 1.8x × equity multiplier 1.67x

Company Overview

Sector

Chemicals

Market Cap

₹1,351 Cr

P/E (TTM)

8.27

ROE

4.38%

Book Value

₹82.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Manali Petrochemicals Lt lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 54/100. The strongest factor is Financial Strength (100/100), while Liquidity (21/100) is the weakest area to weigh before deciding. Notably: Low return on equity (4.38%). Strong 3-year EPS growth (36.9%).

TopFund Score — Fundamentals Quality

54/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

25

Valuation

55

Cash Flow

35

Corporate Governance

68

Momentum

73

Institutional Ownership

30

Business Quality

61

Risk & Volatility

34

Liquidity

21

From Screener.in

  • +Company is almost debt free.
  • +Stock is trading at 0.96 times its book value
  • +Company is expected to give good quarter
  • +Company has been maintaining a healthy dividend payout of 34.4%
  • −The company has delivered a poor sales growth of -0.04% over past five years.
  • −Company has a low return on equity of 3.23% over last 3 years.
  • −Earnings include an other income of Rs.128 Cr.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

MPL reported Q2 FY2027 consolidated income of Rs. 414.37 crore, PAT of Rs. 63.50 crore.

Q2 FY27 standalone and consolidated results approved on 6 Nov 2026; auditor review reports disclosed.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 270 205 256 240 230 196 230 235 248 247 293 275 396
Expenses + 255 200 239 220 226 183 209 212 228 233 268 192 317
Operating Profit 15 5 17 21 4 13 21 23 20 14 25 83 79
OPM % 5.0% 2.5% 7.0% 9.0% 1.7% 6.0% 9.0% 10.0% 8.0% 6.0% 9.0% 30.0% 20.0%
Other Income + 9 8 1 6 6 4 5 8 12 71 25 14 19
Interest 2 2 3 3 2 3 3 3 3 3 4 3 3
Depreciation 6 6 7 7 7 7 7 8 8 9 9 9 9
Profit before tax 15 5 8 18 1 8 16 20 21 72 37 85 85
Tax % 27.0% 35.0% 84.0% 27.0% 64.0% 31.0% 32.0% 28.0% 14.0% 6.0% 22.0% 24.0% 26.0%
Net Profit + 11 3 1 13 0 5 11 14 18 68 29 64 64
EPS in Rs 1 0 0 1 0 0 1 1 1 4 2 4 4
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -5 -14 -23 -20 -15 -4 -10 -2 8 26 27 17 59

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 733 579 626 748 810 803 1,024 1,672 1,181 1,032 897 1,022 1,210
Expenses + 663 511 574 651 710 733 723 1,143 1,103 985 839 940 1,009
Operating Profit 70 68 52 97 100 70 302 529 79 47 58 82 201
OPM % 10.0% 12.0% 8.0% 13.0% 12.0% 9.0% 29.0% 32.0% 7.0% 4.5% 7.0% 8.0% 17.0%
Other Income + 7 9 18 3 27 5 -8 11 24 21 21 116 128
Interest 2 3 2 3 2 6 5 9 9 10 10 14 13
Depreciation 6 6 8 9 11 14 21 20 23 25 27 34 37
Profit before tax 70 69 60 88 113 54 268 511 70 33 42 150 279
Tax % 37.0% 31.0% 37.0% 34.0% 33.0% 14.0% 25.0% 25.0% 28.0% 42.0% 30.0% 14.0% —
Net Profit + 44 48 38 58 77 47 201 381 51 19 29 130 225
EPS in Rs 3 3 2 3 4 3 12 22 3 1 2 8 13
Dividend Payout % 20.0% 18.0% 23.0% 15.0% 17.0% 28.0% 13.0% 11.0% 25.0% 67.0% 29.0% 7.0% —
Sales growth 32 — 8 19 8 -1 28 63 -29 -13 -13 14 33

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 159 196 225 306 369 395 594 944 958 976 1,008 1,195 1,324
Borrowings + 1 2 26 23 34 26 14 19 7 103 129 137 123
Other Liabilities + 162 215 195 141 165 153 198 241 223 144 179 177 208
Total Liabilities 408 499 532 556 654 660 892 1,290 1,274 1,308 1,403 1,596 1,741
Fixed Assets + 105 105 206 273 283 302 292 343 552 559 596 568 587
CWIP 6 16 28 12 6 26 28 14 23 17 61 39 18
Investments 82 69 16 57 0 41 0 0 0 29 15 6 6
Other Assets + 215 310 282 214 364 291 572 933 700 704 731 983 1,130
Total Assets 408 499 532 556 654 660 892 1,290 1,274 1,308 1,403 1,596 1,741
Equity Capital 86 86 86 86 86 86 86 86 86 86 86 86 86

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 78 -6 87 58 13 87 219 373 92 75 -19 116
Cash from Investing Activity + -6 -7 -133 -8 -20 -18 -4 -16 -261 -82 -155 75
Cash from Financing Activity + -14 -11 6 -17 -2 -29 -28 -26 -64 -7 0 -9
Net Cash Flow 58 -24 -39 33 -9 41 186 331 -233 -14 -174 182
Free Cash Flow 68 -22 -36 26 -6 58 194 346 47 50 -120 49
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 155 36 194 86 44 144 95 95 149 170 6 157

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 44.87% → 44.87%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 54.26% 54.33% 53.74% 54.02% 54.07% 54.47% 54.67% 54.69% 54.83% 54.77% 54.75% 54.46%
Promoters 44.87% 44.87% 44.87% 44.87% 44.87% 44.87% 44.87% 44.87% 44.87% 44.87% 44.87% 44.87%
FII 0.86% 0.79% 1.32% 1.1% 1.06% 0.66% 0.45% 0.44% 0.29% 0.37% 0.38% 0.66%
DII 0.02% 0.02% 0.07% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Manali Petrochemicals Lt (this stock) 1,351 8.27 0.96 4.38%
Meghmani Organics Limited 1,349 15.6 0.83 1.9%
India Pesticides Limited 1,333 14.1 1.28 12.5%
Dcw Ltd 1,402 — 1.81 -0.73%
Spic Ltd 1,246 6.53 0.86 15.0%
Excel Industries Ltd 1,246 15.8 0.6 4.62%
Camlin Fine Sciences Ltd 1,469 67.4 1.51 3.75%

Which Mutual Funds Hold Manali Petrochemicals Lt?

Frequently Asked Questions about Manali Petrochemicals Lt

Community Sentiment

What are other investors saying about Manali Petrochemicals Lt?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.